Inflammatory myofibroblastic tumor with RANBP2 and ALK gene rearrangement: A report of two cases and literature review

Diagnostic Pathology

Volumn 8, Issue 1, 2013, Pages

  Li, Jian ^a   Yin, Wei hua ^a   Takeuchi, Kengo ^b,c   Guan, Hong ^d   Huang, Yu hua ^d   Chan, John K C ^e  

^a PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

^b CANCER INSTITUTE   (Japan)

^c CANCER INSTITUTE HOSPITAL   (Japan)

^d SHENZHEN PEOPLE'S HOSPITAL   (China)

^e QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

Fluorescence in situ hybridization; Inflammatory myofibroblastic tumor; RANBP2 ALK

Indexed keywords

ALK RANBP2 FUSION PROTEIN, HUMAN; ALK-RANBP2 FUSION PROTEIN, HUMAN; ANAPLASTIC LYMPHOMA KINASE; CHAPERONE; NUCLEOPORIN; ONCOPROTEIN; PROTEIN TYROSINE KINASE; RAN BINDING PROTEIN 2; RAN-BINDING PROTEIN 2; TUMOR MARKER;

ADULT; BIOPSY; CASE REPORT; CELL SHAPE; COMPUTER ASSISTED TOMOGRAPHY; ENZYMOLOGY; FATALITY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; GENE REARRANGEMENT; GENETIC PREDISPOSITION; GENETICS; HUMAN; INFLAMMATION; INTESTINE TUMOR; MALE; MUSCLE TUMOR; PATHOLOGY; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE; TUMOR VOLUME; YOUNG ADULT;

ADULT; BIOPSY; CELL SHAPE; FATAL OUTCOME; FEMALE; GENE FUSION; GENE REARRANGEMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFLAMMATION; INTESTINAL NEOPLASMS; MALE; MOLECULAR CHAPERONES; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, MUSCLE TISSUE; NUCLEAR PORE COMPLEX PROTEINS; ONCOGENE PROTEINS, FUSION; PHENOTYPE; RECEPTOR PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84883670831     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-8-147     Document Type: Article

References (22)

1. Dehner LP. Inflammatory myofibroblastic tumor: the continued definition of one type of so-called inflammatory pseudotumor. Am J Surg Pathol 2004, 28:1652-1654. 10.1097/00000478-200412000-00016, 15577687.
2. Coffin CM, Patel A, Perkins S, Elenitoba-Johnson KS, Perlman E, Griffin CA. ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol 2001, 14:569-576. 10.1038/modpathol.3880352, 11406658.
3. Takeuchi K, Soda M, Togashi Y, Sugawara E, Hatano S, Asaka R, Okumura S, Nakagawa K, Mano H, Ishikawa Y. Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification. Clin Cancer Res 2011, 17:3341-3348. 10.1158/1078-0432.CCR-11-0063, 21430068.
4. Bridge JA, Kanamori M, Ma Z, Pickering D, Hill DA, Lydiatt W, Lui MY, Colleoni GW, Antonescu CR, Ladanyi M, Morris SW. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. Am J Pathol 2001, 159:411-415. 10.1016/S0002-9440(10)61711-7, 1850566, 11485898.
5. Ma Z, Hill DA, Collins MH, Morris SW, Sumegi J, Zhou M, Zuppan C, Bridge JA. Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 2003, 37:98-105. 10.1002/gcc.10177, 12661011.
6. Yokoyama N, Hayashi N, Seki T, Panté N, Ohba T, Nishii K, Kuma K, Hayashida T, Miyata T, Aebi U. A giant nucleopore protein that binds Ran/TC4. Nature 1995, 376:184-188. 10.1038/376184a0, 7603572.
7. Patel AS, Murphy KM, Hawkins AL, Cohen JS, Long PP, Perlman EJ, Griffin CA. RANBP2 and CLTC are involved in ALK rearrangements in inflammatory myofibroblastic tumors. Cancer Genet Cytogenet 2007, 176:107-114. 10.1016/j.cancergencyto.2007.04.004, 17656252.
8. Chen ST, Lee JC. An inflammatory myofibroblastic tumor in liver with ALK and RANBP2 gene rearrangement: combination of distinct morphologic, immunohistochemical, and genetic features. Hum Pathol 2008, 39:1854-1858. 10.1016/j.humpath.2008.04.016, 18701132.
9. Butrynski JE, D'Adamo DR, Hornick JL, Dal Cin P, Antonescu CR, Jhanwar SC, Ladanyi M, Capelletti M, Rodig SJ, Ramaiya N, Kwak EL, Clark JW, Wilner KD, Christensen JG, Jänne PA, Maki RG, Demetri GD, Shapiro GI. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med 2010, 363:1727-1733. 10.1056/NEJMoa1007056, 3014292, 20979472.
10. Mariño-Enríquez A, Wang WL, Roy A, Lopez-Terrada D, Lazar AJ, Fletcher CD, Coffin CM, Hornick JL. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. Am J Surg Pathol 2011, 35:135-144. 10.1097/PAS.0b013e318200cfd5, 21164297.
11. Kozu Y, Isaka M, Ohde Y, Takeuchi K, Nakajima T. Epithelioid inflammatory myofibroblastic sarcoma arising in the pleural cavity. Gen Thorac Cardiovasc Surg 2013, 24:.
12. Gleason BC, Hornick JL. Inflammatory myofibroblastic tumours: where are we now?. J Clin Pathol 2008, 61:428-437. 10.1136/jcp.2007.049387, 17938159.
13. Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol 2007, 31:509-520. 10.1097/01.pas.0000213393.57322.c7, 17414097.
14. Cook JR, Dehner LP, Collins MH, Ma Z, Morris SW, Coffin CM, Hill DA. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study. Am J Surg Pathol 2001, 25:1364-1371. 10.1097/00000478-200111000-00003, 11684952.
15. Sasaki T, Okuda K, Zheng W, Butrynski J, Capelletti M, Wang L, Gray NS, Wilner K, Christensen JG, Demetri G, Shapiro GI, Rodig SJ, Eck MJ, Jänne PA. The neuroblastoma-associated F1174L ALK mutation causes resistance to an ALK kinase inhibitor in ALK-translocated cancers. Cancer Res 2010, 70:10038-10043. 10.1158/0008-5472.CAN-10-2956, 3045808, 21030459.
16. Röttgers S, Gombert M, Teigler-Schlegel A, Busch K, Gamerdinger U, Slany R, Harbott J, Borkhardt A. ALK fusion genes in children with atypical myeloproliferative leukemia. Leukemia 2010, 24:1197-1200. 10.1038/leu.2010.18, 20428197.
17. Martorell M, Pérez-Vallés A, Gozalbo F, Garcia-Garcia JA, Gutierrez J, Gaona J. Solitary fibrous tumor of the thigh with epithelioid features: a case report. Diagn Pathol 2007, 2:19. 10.1186/1746-1596-2-19, 1913496, 17577399.
18. Kim MJ, Lee SH, Youk EG, Lee S, Choi JH, Cho KJ. Solitary myofibroma of the sigmoid colon: case report and review of the literature. Diagn Pathol 2013, 8:90. 10.1186/1746-1596-8-90, 3711989, 23742153.
19. Cessna MH, Zhou H, Sanger WG, Perkins SL, Tripp S, Pickering D, Daines C, Coffin CM. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases. Mod Pathol 2002, 15:931-938. 10.1097/01.MP.0000026615.04130.1F, 12218210.
20. Uncu H, Tüzüner A. Epithelioid leiomyosarcoma of the gastrocolic ligament. Acta Chir Belg 2003, 103:105-107.
21. Carter JM, O'Hara C, Dundas G, Gilchrist D, Collins MS, Eaton K, Judkins AR, Biegel JA, Folpe AL. Epithelioid malignant peripheral nerve sheath tumor arising in a schwannoma, in a patient with " neuroblastoma-like" schwannomatosis and a novel germline SMARCB1 mutation. Am J Surg Pathol 2012, 36:154-160. 10.1097/PAS.0b013e3182380802, 3241826, 22082606.
22. Hruban RH, Shiu MH, Senie RT, Woodruff JM. Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases. Cancer 1990, 66:1253-1265. 10.1002/1097-0142(19900915)66:6<1253::AID-CNCR2820660627>3.0.CO;2-R, 2119249.